Pediatric Asthma Risk Score Robust Across Diverse Backgrounds
(MedPage Today) -- The Pediatric Asthma Risk Score (PARS) remained an effective tool for estimating asthma risk when used for patients of varying backgrounds, a study of 10 cohorts found. The area under the receiver operating curve (AUC) for the... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - August 14, 2023 Category: Allergy & Immunology Source Type: news

Extreme Temps and Particulate Matter in Fatal Heart Attacks; Impact of Thymectomy
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - August 6, 2023 Category: Allergy & Immunology Source Type: news

Jeanne Marrazzo Chosen to Succeed Fauci as NIAID Director
(MedPage Today) -- Jeanne Marrazzo, MD, will be the next director of the National Institute of Allergy and Infectious Diseases (NIAID), NIH Acting Director Lawrence Tabak, DDS, PhD, announced on Wednesday. "Dr. Marrazzo brings a wealth of leadership... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - August 3, 2023 Category: Allergy & Immunology Source Type: news

Pre-COPD Current and Former Smokers Not in the Clear for Airway Disease
(MedPage Today) -- Whether they had respiratory symptoms or not, former and current smokers who didn't meet criteria for chronic obstructive pulmonary disease (COPD) had similar declines in lung function and progression to COPD in subsequent years... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - August 2, 2023 Category: Allergy & Immunology Source Type: news

Pediatric Allergic March Supported by Nationwide EHR Data
(MedPage Today) -- A typical allergic march started with atopic dermatitis during infancy and progressed to other allergies later in life, a multi-state study found. In total, 13.4% of pediatric study participants had two or more allergic conditions... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - July 27, 2023 Category: Allergy & Immunology Source Type: news

Nixing Food Triggers Could Ease More Eosinophilic GI Disorders
(MedPage Today) -- An amino-acid based diet may help provide relief for patients with eosinophilic gastritis or gastroenteritis (EoG/EoGE), a small prospective study found. All 15 participants experienced a complete histologic remission in both... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - July 20, 2023 Category: Allergy & Immunology Source Type: news

Infant Egg Allergy Unaffected by Mom's Early Postnatal Diet
(MedPage Today) -- Infants were no less likely to develop egg allergy if their mother ate eggs in the days after delivery as a means of low-dose oral immunotherapy via breast milk, a randomized clinical trial showed. At 12 months of age, egg allergy... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - July 10, 2023 Category: Allergy & Immunology Source Type: news

Food Allergy Burden Higher in Black, Hispanic, and Asian Americans
(MedPage Today) -- A nationally representative sample of the U.S. population found that Black, Hispanic, and Asian Americans of all ages carry the highest burden of food allergies, researchers reported. Survey data collected from more than 50... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - June 15, 2023 Category: Allergy & Immunology Source Type: news

Schools Aren't Prepared to Treat Asthma Attacks
(MedPage Today) -- Asthma affects 8.6% of children in the U.S. Children in high-burden areas, including inner-city and rural areas, are disproportionately affected due to barriers to care and environmental factors. Asthma exacerbations account... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - June 6, 2023 Category: Allergy & Immunology Source Type: news

Dual Phosphodiesterase Inhibitor Improved Lung Function in COPD Patients
(MedPage Today) -- WASHINGTON -- Treatment with the first-in-class dual phosphodiesterase 3/4 inhibitor ensifentrine reduced exacerbation rates and improved other key outcomes in patients with chronic obstructive pulmonary disease (COPD), according... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 25, 2023 Category: Allergy & Immunology Source Type: news

Biologic Reduced Cough, Phlegm in Severe, Uncontrolled Asthma
(MedPage Today) -- WASHINGTON -- Patients with severe, uncontrolled asthma taking tezepelumab (Tezspire) reported significantly improved cough and phlegm production, compared with patients taking placebo, in a secondary analysis of the phase... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 24, 2023 Category: Allergy & Immunology Source Type: news

Real-World Data on COPD Combo Inhalers Favor LAMA-LABAs
(MedPage Today) -- Chronic obstructive pulmonary disease (COPD) patients starting on a combination maintenance inhaler had better outcomes if they were prescribed one containing a long-acting muscarinic antagonist and long-acting beta-agonist ... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 23, 2023 Category: Allergy & Immunology Source Type: news

Dupilumab Reduces COPD Exacerbations
(MedPage Today) -- WASHINGTON -- Among chronic obstructive pulmonary disease (COPD) patients with type 2 inflammation at high risk for exacerbations despite being on standard triple therapy, adding dupilumab (Dupixent) was associated with clinically... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 22, 2023 Category: Allergy & Immunology Source Type: news

Kids' Asthma Improves After Moving to Better-Resourced Neighborhoods
(MedPage Today) -- A program that helped families move to a low-poverty neighborhood was linked with a significant improvement in symptoms and exacerbations among children with persistent asthma, a cohort study out of Baltimore showed. Prior to... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 17, 2023 Category: Allergy & Immunology Source Type: news

FDA Staff Grapples With Absent Clinical Efficacy Data for Nasal Epinephrine
(MedPage Today) -- A lack of clinical efficacy data on epinephrine nasal spray remained a chief concern for FDA reviewers as the agency considers approval of the first noninjectable product for treating allergic reactions, including anaphylaxis... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 10, 2023 Category: Allergy & Immunology Source Type: news